Northern Trust Corp My Md Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.44 - $2.26 $351 - $551	-244 Reduced 0.41%	59,846 $89,000
Q1 2023 May 15, 2023	BUY	$1.1 - $2.86 $5,207 - $13,539	4,734 Added 8.55%	60,090 $103,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $2,675 - $99,051	1,205 Added 2.23%	55,356 $144,000
Q1 2022 May 13, 2022	SELL	$3.34 - $6.05 $8,049 - $14,580	-2,410 Reduced 4.26%	54,151 $252,000
Q3 2021 Nov 15, 2021	BUY	$4.64 - $7.94 $155,495 - $266,085	33,512 Added 145.39%	56,561 $407,000
Q2 2021 Aug 13, 2021	BUY	$3.39 - $6.98 $78,136 - $160,882	23,049 New	23,049 $145,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.